Disclosures for "Predicting the First Attack: Comparison of 2023 Radiologically Isolated Syndrome and 2024 McDonald Criteria"
-
The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
-
Ahmed Serkan Emekli has nothing to disclose.
-
Dr. Barburoglu has nothing to disclose.
-
Dr. Ozakbas has nothing to disclose.
-
Prof. Piri Cinar has nothing to disclose.
-
Dr. Kaya has nothing to disclose.
-
Dr. Demir has nothing to disclose.
-
Dr. gungor dogan has nothing to disclose.
-
Dr. Cetinkaya Tezer has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Ercan has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Karabudak has nothing to disclose.
-
Dr. Acar Ozen has nothing to disclose.
-
Dr. Demirel has nothing to disclose.
-
Dr. Cilingir has nothing to disclose.
-
Dr. Seferoglu has nothing to disclose.
-
Ozlem Ethemoglu has nothing to disclose.
-
Dr. SIVACI has nothing to disclose.
-
Sami Omerhoca has nothing to disclose.
-
Dr. Kale has nothing to disclose.
-
Dr. Derle ciftci has nothing to disclose.
-
Munire Kilinc Toprak has nothing to disclose.
-
Dr. Ugur has nothing to disclose.
-
LEVENT OCEK, 4284 has nothing to disclose.
-
Dr. Ciftci Gedik has nothing to disclose.
-
Cihat Uzunkopru has nothing to disclose.
-
Dr. Beckmann has nothing to disclose.
-
Haluk Gumus has nothing to disclose.
-
Sedat Sen has nothing to disclose.
-
Dr. Kurtuncu has nothing to disclose.